Compugroup Medical (COP) PT Set at €53.50 by Warburg Research

Warburg Research set a €53.50 ($62.21) price objective on Compugroup Medical (ETR:COP) in a report published on Monday morning. The brokerage currently has a buy rating on the stock.

Several other brokerages also recently issued reports on COP. Commerzbank set a €53.00 ($61.63) price target on Compugroup Medical and gave the company a buy rating in a report on Tuesday, October 9th. Baader Bank set a €46.00 ($53.49) price target on Compugroup Medical and gave the company a neutral rating in a report on Monday, July 30th. Berenberg Bank set a €49.00 ($56.98) price target on Compugroup Medical and gave the company a neutral rating in a report on Monday, July 16th. HSBC set a €57.00 ($66.28) price target on Compugroup Medical and gave the company a buy rating in a report on Wednesday, July 4th. Finally, Hauck & Aufhaeuser set a €36.00 ($41.86) price target on Compugroup Medical and gave the company a sell rating in a report on Friday, August 31st. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the stock. Compugroup Medical currently has a consensus rating of Buy and a consensus price target of €52.19 ($60.68).

Shares of Compugroup Medical stock opened at €47.68 ($55.44) on Monday. Compugroup Medical has a 1 year low of €40.10 ($46.63) and a 1 year high of €60.30 ($70.12).

Compugroup Medical Company Profile

CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.

Featured Story: Exchange-Traded Funds (ETFs)

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply